-
Innovation Ranking
Innovation Ranking - Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc (Corvus Pharma) is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of immuno-oncology therapies that are used for treating cancer. Corvus Pharma's product candidate is CPI-444, an oral, small molecule antagonist of the A2A receptor that is in phase I clinical trial for adenosine, an immune checkpoint. The company also develops a product candidate, an anti-CD73 monoclonal antibody that inhibits the production of adenosine produced by the tumor cells. Corvus Pharma’s product pipeline...
-
Innovation Ranking
Innovation Ranking - Syneos Health Inc
Syneos Health Inc (Syneos Health), formerly INC Research Holdings Inc, is a biopharmaceutical services organization that offers product development and commercial solutions. The company provides clinical development services spanning Phase I to Phase IV, such as full-service global studies, clinical monitoring, patient recruitment, investigator recruitment, data management, and other services. Its commercial solutions include communications, medication adherence and consulting services. Syneos Health offers its solutions for large and small to mid-sized companies across biotechnology, biopharmaceutical, and medical device industries. The...
-
Innovation Ranking
Innovation Ranking - Rubius Therapeutics Inc
Rubius Therapeutics Inc (Rubius Therapeutics) is a biotechnology company. It focuses on the development of medicines for the treatment of rare diseases, cancer and autoimmune diseases. The company's RCT pipeline products comprise of RTX-240, RTX-321 aAPC, RTX-224, RTX-aAPC, and RTX-T1D. Its products under development are intended for the treatment of human papillomavirus 16-positive cancers, non-small cell lung cancer, type 1 diabetes, cutaneous melanoma, head and neck squamous cell carcinoma, urothelial (bladder) carcinoma and triple-negative breast cancer. The company also offers...
-
Innovation Ranking
Innovation Ranking - X4 Pharmaceuticals Inc
X4 Pharmaceuticals Inc, formerly Arsanis Inc, is a clinical stage bio pharmaceutical company that develops oral, small molecule therapeutics to treat cancer and rare diseases. The company’s pipeline products include Mavorixafor, an allosteric inhibitor of CXCR4 for the treatment of Warts, Hypogammaglobulinemia, Immunodeficiency and Myelokathexis (WHIM) syndrome X4P-002 and X4P-003, small molecule antagonists of chemokine receptor CXCR4 for treating glioblastoma multiforme and primary immune deficiencies (PI's). The company is developing oral allosteric antagonists of CXCR4 in order to block overstimulation...
-
Innovation Ranking
Innovation Ranking - Nien Made Enterprise Co., Ltd.
Nien Made Enterprise Co Ltd (Nien Made) is a manufacturer and distributor of custom curtains. The company offers products such as Shutters, Cellular Shades, Blinds, Roller Shades, Roman Shades, and BelleVue Shades. Nien Made offers blinds and wood shutters under the brand names NORMAN and VENETA. It also designs, manufactures, and sells automated appliances and PVC tubes. In addition, it also engages in manufacturing and selling dehumidifiers and air purifiers; the provision of logistics support services and window coverings documentation...
-
Innovation Ranking
Innovation Ranking - MeiraGTx Holdings Plc
MeiraGTx Holdings Plc (MeiraGTx) is a gene therapy company that develops treatments for ocular, salivary gland and central nervous system diseases. It is investigating AAV-RPGR program against X-linked retinitis pigmentosa (XLRP); AAV-RPE65 gene therapy to treat RPE65 (retinal pigment epithelium-specific 65 kDa) gene deficiency; AAV-CNGB3 drug for achromatopsia (ACHM); and A006 program targeting wet AMD (age-related macular degeneration). The company is also evaluating AAV-GAD medicine to treat Parkinson’s disease; AAV-UPF1 against amyotrophic lateral sclerosis (ALS); AAV-AQP1 for radiation-induced xerostomia (RIX);...
-
Innovation Ranking
Innovation Ranking - Peloton Interactive Inc
Peloton Interactive Inc (Peloton Interactive), formerly Peloton Interactive LLC, offers bikes, tread, fitness apparel and accessories. The company's product portfolio comprises internet-connected stationary bikes, treadmills, cycling shoes, dumbbells, resistance bands, and fitness apparel. It also provides connected fitness subscriptions, access to live and on-demand fitness group classes at home that are led by its instructors, and the Peloton Digital app for household users to access its classes. Peloton Interactive sells its products directly to customers through a multi-channel sales platform...
-
Innovation Ranking
Innovation Ranking - Kaleido Biosciences Inc
Kaleido Biosciences Inc (Kaleido) is a pharmaceutical company. It carries out the design and development of human microbiomes for the treatment of infectious, inflammatory, oncology, and metabolic diseases. Its proprietary product platform enables the discovery and development of novel microbiome metabolic therapies which are designed to modulate the metabolic output by function and distribution of the gut’s existing microbes. The company is investigating KB195, for treatment of urea cycle disorders; KB174, targeting hepatic encephalopathy; KB295, for treating inflammatory bowel disease;...
-
Innovation Ranking
Innovation Ranking - Genscript Biotech Corp
Genscript Biotech Corp (Genscript) is a biotechnology company that provides life science research and applications solutions. The company’s product portfolio comprises antibodies, recombinant proteins, stable cell lines, molecular biology reagents, peptides and biochemicals, CRISPR Cas reagents and others. It provides peptide synthesis, genome editing, cell engineering, mutation and library solutions, preclinical drug development, biologics and manufacturing solutions. GenScript products find application in life science research, vaccine development, immunotherapy, COVID-19 and drug discovery and development. The company utilizes its proprietary gene...
-
Innovation Ranking
Innovation Ranking - Leap Therapeutics Inc
Leap Therapeutics Inc (Leap Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapeutics to treat patients with different types of cancer. The company’s pipeline products include DKN-01. DKN-1 is a monoclonal antibody that targets the Dickkopf-1 (DKK-1) protein, intended for the treatment of gastroesophageal cancer, prostate cancer and gynecologic cancer. FL-301, a monoclonal antibody that targets Claudin18.2, is being tested in patients with gastric and pancreatic cancer. The company has an agreement with BeiGene Ltd for development rights and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.